Purpose of the development: Hemosorbent HSGD intended for the treatment of diseases caused by hitting the outside, or by an excessive accumulation in the body's own protein and membrane-bound toxins and metabolites.

Recommended application field: Medicine.

Technical characteristic: Features hemosorbent HSGD : 1. Hemosorbent HSGD produced packaged in disposable column sorption (CSR ) with a capacity of 50, 100 , 200, 300 ml. 2 . Contents working fraction of at least 90 % of the total weight . 3 . Sorption pore volume of benzene at least 1.2 cm3 per 1 g HSGD . 4 . Bulk weight in HSGD in 1 cm3 of not more than 0.26 g 5 . Dustiness less than 5% . 6. Container according to bilirubin in the adsorption of the albumin- containing solution is not less than 6 mg / m 7. Container according to the adsorption of phenol with albumin - containing solution is not less than 60 mg / g 8. Container according to creatinine in the adsorption buffer solution of at least 85 mg / g 9. Container according to uric acid in the adsorption buffer solution of at least 75 mg / g 10 . Reducing the number of platelets and leukocytes due to their landing HSGD initial contact with the blood of sorbent granule no more platelets - 10% by leukocytes - 15 %. 11. Increase of free hemoglobin not exceeding 10 mg%. 12. Hemosorbents HSGD sterile, non-pyrogenic , non-toxic. 13. Example of designation when ordering hemosorbent granulated deligand HSGD 100 ml - " hemosorbent HSGD - 100 TU 88 258.009-94 ."

Advantages over analogues: Has a high capacity in relation to unconjugated bilirubin, free fatty acids, bile acids, phenols, mercaptans, and a variety of uremic metabolites and burn, blocking transport function of serum albumin and erythrocyte membranes. Using hemosorbent HSGD provides a qualitatively new therapeutic effects associated with deep cleaning of proteins and cell membranes of blood.

The development stage readiness: Introduced in production

Description of the development:
()
Hemosorbent granular deligandizuyuschy (HSGD) - a synthetic carbon hemosorbent third generation, combining usual properties of high activated carbons with the ability to effectively remove protein-bound substances and toxins. Indications for use: - Acute and chronic liver failure - Acute and chronic renal failure - Burn toxemia - sepsis - peritonitis - Acute and chronic radiation sickness - Poisoning by some poisons and drugs and others.

Certif №9267/2010

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Technological document's sale
Creation of joint enterprise
Realization of finished commodity

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua